Travellers with pre-existing medical conditions

International Journal of Antimicrobial Agents

Volumn 21, Issue 2, 2003, Pages 181-188

  Ericsson, Charles D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Asplenia; Chronic obstructive pulmonary disease; Corticosteroids; Diabetes mellitus; End stage renal disease myocardial infarction; Gastrointestinal disease: cirrhosis; HIV; IgA deficiency; Immune compromised host; Malignancy; Transplantation; Travel; Travellers

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MALARIA VACCINE; MEASLES VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; VARICELLA ZOSTER VACCINE; VIRUS VACCINE; YELLOW FEVER VACCINE;

ARTICLE; ASPLENIA; CANCER; CHEMOPROPHYLAXIS; DIABETES MELLITUS; DIPHTHERIA; EDUCATION; EPIDEMIC ENCEPHALITIS; GASTROINTESTINAL DISEASE; HEALTH PRACTITIONER; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNITY; IMMUNOGLOBULIN A DEFICIENCY; INFLUENZA; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER FUNCTION; LUNG FUNCTION; MALARIA; MEASLES; MENINGOCOCCOSIS; NONHUMAN; PRIORITY JOURNAL; RABIES; RISK ASSESSMENT; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; STRONGYLOIDES STERCORALIS; TETANUS; TICK BORNE ENCEPHALITIS; TRANSPLANTATION; TRAVEL; TUBERCULOSIS; TYPHOID FEVER; VACCINATION;

DIABETES MELLITUS; GASTROINTESTINAL DISEASES; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; NEOPLASMS; PATIENT EDUCATION; PREVENTIVE MEDICINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RENAL DIALYSIS; RISK FACTORS; SPLENECTOMY; TRANSPLANTATION IMMUNOLOGY; TRAVEL; VACCINATION;

EID: 0037293069     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00288-1     Document Type: Article

References (16)

1. Mileno D.M., Bia F.J. Travel medicine: the compromised traveller. Infect. Dis. Clin. North Am. 12:1998;369-412.
2. Castelli F., Patroni A. The human immunodeficiency virus-infected traveller. Clin. Infect. Dis. 31:2000;1403-1408.
3. Gruenewald R., Blum S., Chan J. Relationship between human immunodeficiency virus infection and salmonellosis in 20-50-year-old residents of New York City. Clin. Infect. Dis. 18:1994;358.
4. Fischer P., Kipp W., Kabwa P., et al. Onchocerciasis and human immunodeficiency virus in western Uganda: prevalences and treatment with ivermectin. Am. J. Trop. Med. Hyg. 53:1995;171.
5. Karanja D.M., Colley D.G., Nahlen B.L., et al. Studies on schistosomiasis in western Kenya: evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus co-infections. Am. J. Trop. Med. Hyg. 56:1997;515.
6. Lynch A.M., Kapila R. Overwhelming postsplenectomy infection. Infect. Dis. Clin. North Am. 10:1996;693.
7. Lewis K.T., Stiles M. Management of cat and dog bites. Am. Fam. Phys. 52:1995;479.
8. Styrt B.A. Risks of infection and protective strategies for the asplenic patient. Infect. Dis. Clin. Pract. 5:1996;94.
9. Gilbert D.N., Moellering R.C., Sande M.A. The Sanford guide to antimicrobial therapy. 32nd ed. 2002;Antimicrobial Therapy, Hyde Park, VT.
10. Driessen S.O., Cobelens F.G.J., Ligthelm R.J. Travel-related morbidity in travellers with insulin-dependent diabetes mellitus. J. Travel. Med. 6:1999;12-15.
11. Gill G.V., Redmond S. Insulin treatment, time-zones and air travel: a survey of current advice from British diabetic clinics. Diabetic Med. 10:1993;764.
12. Midthjell Km Kapelrud H., Bjornerud A., et al. Severe or life-threatening hypoglycemia in insulin pump treatment. Diabetes Care. 17:1994;1235.
13. Giordano B.P., Thrash W., Holenbaugh L., et al. Performance of seven blood glucose testing systems at high altitude. Diabetes Educ. 15:1989;444.
14. Sane T., Kovisto V.A., Nikkanen P., et al. Adjustment of insulin doses of diabetic patients during long distance flights. Br. Med. J. 301:1990;421.
15. Smeets F. Travel for technology-dependent patients with respiratory disease. Thorax. 49:1994;77.
16. Cox G.R., Peterson J., Bouchel L., et al. Safety of commercial air travel following myocardial infarction. Aviat. Space Environ. Med. 67:1996;976.